Singapore Association of Pharmaceutical Industries

Singapore Association of Pharmaceutical Industries The Singapore Association of Pharmaceutical Industries (SAPI) aims to make innovative medicines acce

As Singapore gears up to introduce the Health Information Bill (HIB), SAPI is privileged to share its suggestions to the...
12/04/2024

As Singapore gears up to introduce the Health Information Bill (HIB), SAPI is privileged to share its suggestions to the provisions, ensuring the bill maximises its potential to drive healthcare innovation and efficiency for our healthcare ecosystem.

Swipe through our slides to learn more.

Patients are at the heart of our newly launched Guidelines for Interactions with Patients, Caregivers and Patient Organi...
18/03/2024

Patients are at the heart of our newly launched Guidelines for Interactions with Patients, Caregivers and Patient Organisations ( https://www.sapi.org.sg/wp-content/uploads/2024/03/SAPI-Guidelines-for-Interactions-with-Patients-Caregivers-and-Patient-Organisations.pdf), so it is fitting we share some insights from patient representatives who played a crucial role in shaping these guidelines.

Swipe right for insights from Mr. Phua Wee Seng, Chief Rare Advocate, Rare Disorders Society (Singapore) , Ms. Nidhi Swarup, Founding Chair, Alliance of Patients' Organizations Singapore (APOS) and Mr. Satyaprakash Tiwari, Executive Director, Diabetes Singapore, about how the guidelines mark a significant step forward for the patient communities who are seeking to be heard and valued in healthcare conversations.

Last week, we introduced our new Guidelines for Interactions with Patients, Caregivers, and Patient Organisations ( http...
12/03/2024

Last week, we introduced our new Guidelines for Interactions with Patients, Caregivers, and Patient Organisations (https://www.sapi.org.sg/wp-content/uploads/2024/03/SAPI-Guidelines-for-Interactions-with-Patients-Caregivers-and-Patient-Organisations.pdf ), marking a pivotal moment for ethical and patient-centric healthcare. This week, we're taking you behind the scenes to reveal the thought process and ambition driving this initiative.

Join Ms. Quek Wee Ling, Mr. Reuben Ong and Ms. Christina Teo as they share their insights on crafting these guidelines and the transformative impact they envision for our healthcare system.

We are thrilled to unveil our latest initiative aimed at fostering ethical, transparent, and respectful collaborations b...
06/03/2024

We are thrilled to unveil our latest initiative aimed at fostering ethical, transparent, and respectful collaborations between the pharmaceutical industry and patient representatives. Our newly published guidelines represent a significant step forward in ensuring patient-centric engagement practices. Developed through extensive collaboration within the industry and with input from patient organisations, these guidelines set a new standard for collaboration and partnership.

By adhering to these practices, we can build stronger, more meaningful relationships that prioritize patient needs and contribute to better engagement outcomes. We invite you to explore the full document and join us in embracing these principles in your interactions.

Read more and download the guidelines here:https://www.sapi.org.sg/wp-content/uploads/2024/03/SAPI-Guidelines-for-Interactions-with-Patients-Caregivers-and-Patient-Organisations.pdf

This week, we're thrilled to spotlight the SAPI Patient Engagement & Partnership (PEP) Workstream. Led by Ms. Quek Wee L...
28/02/2024

This week, we're thrilled to spotlight the SAPI Patient Engagement & Partnership (PEP) Workstream. Led by Ms. Quek Wee Ling and operating within the Public Policy Committee (PPC), PEP aims to foster an environment where patients are at the heart of healthcare innovation and decision-making.

Currently, PEP is focused on two initiatives: creating guidelines aimed at promoting ethical interactions between the pharmaceutical industry and patient communities and equipping patient organisations with the tools they need to effectively advocate for their communities.

We look forward to the positive impact our initiatives will have on fostering a more inclusive and patient-focused dialogue in healthcare. Stay tuned for exciting updates and the upcoming release of our new guidelines!

In today’s  , we focus on the Supply Chain Committee (SCC), chaired by Ms Tan Yan Ann, who has over 23 years of experien...
23/02/2024

In today’s , we focus on the Supply Chain Committee (SCC), chaired by Ms Tan Yan Ann, who has over 23 years of experience in supply chain management.

The committee, comprising a broad mix of experienced supply chain, market access, finance, tender and pricing leaders amongst others, functions as a central communication hub between SAPI members and external stakeholders to facilitate a seamless exchange of ideas, insights, and best practices. This collaborative model fosters an environment of continuous improvement and ensures the resilience of the pharmaceutical supply chain.

As we welcome the   announcement, the future of healthcare is already in motion. SAPI and its members are committed to m...
16/02/2024

As we welcome the announcement, the future of healthcare is already in motion. SAPI and its members are committed to making innovative medicines and vaccines accessible to patients in Singapore and collaborating for a healthier future.

We have 2 key aspirations:
1️⃣ Co-creating financially sustainable solutions for a healthier Singapore
2️⃣ Building on Healthier SG efforts

By leveraging on the power of collective action, we can ensure timely access to life-saving innovations while maintaining a resilient and accessible healthcare system.

Join us in this crucial conversation! Share your thoughts on the future of Singapore's healthcare in the comments below.

The third post in the   series focuses on the Ethics & Business Integrity Committee (EBIC), chaired by Mr Reuben Ong for...
23/01/2024

The third post in the series focuses on the Ethics & Business Integrity Committee (EBIC), chaired by Mr Reuben Ong for the past five years. The committee, comprising 20 member companies, plays a crucial role in guiding the pharmaceutical industry to uphold ethical decision-making and business integrity, with the ultimate aim of advancing patients’ health and well-being.

Today, we shine the spotlight on SAPI’s Research and Development Committee (RDC), chaired by Ms Yeoh Ying Ying, who is a...
05/01/2024

Today, we shine the spotlight on SAPI’s Research and Development Committee (RDC), chaired by Ms Yeoh Ying Ying, who is also SAPI Board Vice President. The RDC was established to support and enable innovative research to advance patient care, with a specific focus on improving the competitiveness of Singapore as a destination for local, regional and global clinical trials through the Clinical Trial Working Group (CTWG), a sub-committee under RDC comprising representatives from 13 companies.

SAPI continuously collaborates with regulatory bodies and key industry stakeholders to promote the exchange of ideas and...
28/12/2023

SAPI continuously collaborates with regulatory bodies and key industry stakeholders to promote the exchange of ideas and share best practices, with the goal of ensuring that patients enjoy timely access to life-changing therapies.

Professor John CW Lim, Executive Director of the Centre of Regulatory Excellence (CoRE), Duke-National University of Singapore Medical School (Duke-NUS) shares his insights on how the globally-recognised HSA regulatory system enables efficient authorisation of new therapeutic products, to ensure that patients continually have access to the latest medical innovations.

Address

151 Chin Swee Road
Singapore
169876

Opening Hours

Monday 09:00 - 17:00
Tuesday 09:00 - 17:00
Wednesday 09:00 - 17:00
Thursday 09:00 - 17:00
Friday 09:00 - 17:00

Telephone

+6567380966

Alerts

Be the first to know and let us send you an email when Singapore Association of Pharmaceutical Industries posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share